Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Immunological Medicines for Pigs

Immunological veterinary medicinal products, including vaccines, are authorised for pigs.

Search results 51 to 75 from a total of 85

Name De­scrip­tion Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date An­i­mal Further Information

Porcilis Parvo

Parvovirose

Intervet Deutschland GmbH

211a/94 04.11.1998 Schwein

Porcilis PCV

Circovirus-Infektion

Intervet International B.V., Niederlande

EU/2/08/091/001-010 12.01.2009 Schwein

EPAR: Porcilis PCV

Porcilis PCV ID

Circovirus-Infektion

Intervet International B.V., Niederlande

EU/2/15/187/001-004 28.08.2015 Schwein

EPAR: Porcilis PCV ID

Porcilis PCV M Hyo

Circovirus-Infektion, Enzootische Pneumonie

Intervet International B.V., Niederlande

EU/2/14/175/001-010 07.11.2014 Schwein

EPAR: Porcilis PCV M Hyo

Porcilis Porcoli Diluvac Forte

E. coli-Ferkelenteritis

Intervet International BV, Niederlande

EU/2/96/001/003-008 22.05.2002 Schwein

EPAR: Porcilis Porcoli Diluvac Forte

Porcilis PRRS

PRRS

Intervet Deutschland GmbH

PEI.V.01706.01.1 03.11.2000 Schwein

Progressis

PRRS

Ceva Tiergesundheit GmbH

PEI.V.01709.01.1 28.11.2000 Schwein, Jungsau, Zuchtsau

ReproCyc ParvoFLEX

Parvovirose

Boehringer Ingelheim Vetmedica GmbH

EU/2/19/237 26.04.2019 Schwein

EPAR: ReproCyc ParvoFLEX

ReproCyc PRRS EU

PRRS

Boehringer Ingelheim Vetmedica GmbH

PEI.V.11723.01.1 24.03.2015 Schwein

RESPIPORC Flu 3

Schweineinfluenza

CEVA Santé Animale

EU/2/09/103/001-006 14.01.2010 Schwein

EPAR: Respiporc Flu 3

RESPIPORC FLUpan H1N1

Schweineinfluenza

CEVA Santé Animale

EU/2/17/209/001-002 17.05.2017 Schwein

EPAR: Respiporc Flupan H1N1

Rhiniseng

Rhinitis atrophicans

Laboratorios Hipra, S.A., Spanien

EU/2/10/109/001-009 16.09.2010 Schwein

EPAR: Rhiniseng

Rindertuberkulin - PPD

Tuberkulin zur Diagnose der Rinder­tuberkulose beim Rind und anderen Haus­säugern

WdT - Wirtschafts­genossen­schaft Deutscher Tierärzte eG

458a/85 28.06.2007 Hund, Rind, Schaf, Schwein, Ziege

SALMOPORC

Salmonellen-Infektion

Ceva Tiergesundheit GmbH

PEI.V.02340.01.1 25.07.2002 Schwein

Stellamune Mykoplasma

Enzootische Pneumonie

Elanco GmbH

145a/93 19.06.1995 Schwein

Stellamune One

Enzootische Pneumonie

Elanco GmbH

PEI.V.02633.01.1 05.06.2002 Schwein

Suigen APP 2, 9, 11

Actinobazillus pleuropneumonie

VIRBAC, Frankreich

PEI.V.12153.01.1 12.06.2023 Schwein

Suigen Entero 3

E. coli-Infektion, Rotavirus-Infektion, Clostridien-Infektion

Bioveta a.s., Tschechien

PEI.V.12174.01.1 29.04.2024 Schwein

Suigen Rota Coli

E. coli-Infektion, Rotavirus-Infektion

Virbac S.A., Frankreich

PEI.V.12117.01.1 13.06.2021 Schwein

Suiseng

E. coli-Enterotoxikose, Nekrotisierende Enteritis, Clostridien-Infektion

Laboratorios Hipra, S.A., Spanien

PEI.V.04349.01.1 07.09.2009 Schwein

Suiseng Coli / C

E. coli-Infektion, Clostridien-Infektion

Laboratorios Hipra S.A., Spanien

PEI.V.12026.01.1 01.04.2020 Schwein

Suiseng Diff/A

Clostridien-Infektion (Clostridioides difficile, Clostridium perfringens)

Laboratorios Hipra, S.A., Spanien

EU/2/21/278 07.12.2021 Schwein

EPAR: Suiseng Diff/A

Suivac APP

Actinobacillus Pleuropneumonie

ChemVet DK A/S, Dänemark

PEI.V.11863.01.1 01.09.2016 Schwein

Suvaxyn Aujeszky 783 + o/w

Aujeszky'sche Krankheit

Zoetis Belgium S.A., Belgien

EU/2/98/009/001-006 10.08.1998 Schwein

EPAR Suvaxyn Aujeszky

Suvaxyn Circo

Circovirus-Infektion

Zoetis Belgium S.A., Belgien

EU/2/17/223/001-006 07.02.2018 Schwein

EPAR: Suvaxyn Circo

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 520 in BAnz AT 22.08.2024 B6.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 22.08.2024